128 related articles for article (PubMed ID: 2962837)
1. The utility of a long-acting sympathomimetic agent, procaterol, for nocturnal asthma.
Baughman RP; Loudon RG
Chest; 1988 Feb; 93(2):285-8. PubMed ID: 2962837
[TBL] [Abstract][Full Text] [Related]
2. A placebo-controlled trial of procaterol: a new long-acting oral beta 2-agonist in bronchial asthma.
Siegel SC; Katz RM; Rachelefsky GS; Brandon ML; Borgen LA
J Allergy Clin Immunol; 1985 Jun; 75(6):698-705. PubMed ID: 2861219
[TBL] [Abstract][Full Text] [Related]
3. Possible site of bronchodilation due to inhaled procaterol aerosol in asthmatic patients.
Taguchi O; Hida W; Nogami H; Inoue H; Takishima T
Eur J Clin Pharmacol; 1988; 34(5):433-7. PubMed ID: 2974417
[TBL] [Abstract][Full Text] [Related]
4. [The inhibitory effect of long-acting beta-adrenergic agonists, mabuterol, clenbuterol and fenoterol on "morning dipping" in patients with asthma].
Yamamoto H; Nagata M; Tabe K; Suzuki S; Maruo H; Sakamoto Y; Yamamoto K; Dohi Y
Arerugi; 1990 Jan; 39(1):21-7. PubMed ID: 1972011
[TBL] [Abstract][Full Text] [Related]
5. Maximum bronchodilator effect of pirbuterol and procaterol administered as sprays with and without an aerochamber.
Solé D; Villalba SR; Sestelo MR; Scalabrin DM; Soares FJ; Naspitz CK
Rev Paul Med; 1993; 111(3):397-402. PubMed ID: 8108632
[TBL] [Abstract][Full Text] [Related]
6. [Bronchial asthma treated with long-acting beta 2 agonist. Comparison between formoterol (12 mu/g) inhaled twice daily and salbutamol (200 mu/g) inhaled 4 times daily].
Sprogøe-Jakobsen U; Viktrup L; Davidsen O; Viskum K
Ugeskr Laeger; 1992 Nov; 154(47):3325-8. PubMed ID: 1361083
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of procaterol combined with inhaled budesonide for treatment of cough-variant asthma.
Bao W; Chen Q; Lin Y; Liu H; Zhao G; Chen Z; Zhou X
Respirology; 2013 Nov; 18 Suppl 3():53-61. PubMed ID: 24188204
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and duration of action of oral procaterol in asthmatic children after single administration of different dosages.
Boner AL; Zanotto CE; Piacentini G; Miglioranzi P; Richelli C; Sette L
J Asthma; 1990; 27(1):21-30. PubMed ID: 2137815
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy and equivalence of tablet and syrup formulations of procaterol hydrochloride in childhood asthma.
Kemp JP; Welch MJ; Meltzer EO; Orgel HA
Ann Allergy; 1985 Oct; 55(4):588-92. PubMed ID: 2864890
[TBL] [Abstract][Full Text] [Related]
10. The effect of procaterol treatment on beta-adrenergic bronchodilation and polymorphonuclear leukocyte responsiveness.
Busse WW; Sharpe G; Smith A; Arbabian M; Borgen L; Ruoho A
Am Rev Respir Dis; 1985 Dec; 132(6):1194-8. PubMed ID: 3000233
[TBL] [Abstract][Full Text] [Related]
11. Procaterol metered aerosol in patients with chronic obstructive pulmonary disease.
Baronti A; Lelli M; Manini G; Verdiani P
Int J Clin Pharmacol Res; 1987; 7(5):363-8. PubMed ID: 2889678
[TBL] [Abstract][Full Text] [Related]
12. Lung sound analysis for continuous evaluation of airflow obstruction in asthma.
Baughman RP; Loudon RG
Chest; 1985 Sep; 88(3):364-8. PubMed ID: 4028846
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma.
Rabe KF; Jörres R; Nowak D; Behr N; Magnussen H
Am Rev Respir Dis; 1993 Jun; 147(6 Pt 1):1436-41. PubMed ID: 8503554
[TBL] [Abstract][Full Text] [Related]
14. Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.
D'Alonzo GE; Nathan RA; Henochowicz S; Morris RJ; Ratner P; Rennard SI
JAMA; 1994 May; 271(18):1412-6. PubMed ID: 7909853
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of a new selective beta 2-adrenoceptor agonist, procaterol and salbutamol in asthma.
Crowe MJ; Counihan HE; O'Malley K
Br J Clin Pharmacol; 1985 Jun; 19(6):787-91. PubMed ID: 2862893
[TBL] [Abstract][Full Text] [Related]
16. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
Chhabra SK
Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
[TBL] [Abstract][Full Text] [Related]
17. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
[TBL] [Abstract][Full Text] [Related]
18. The 24 h duration of bronchodilator action of the budesonide/formoterol combination inhaler.
Masoli M; Williams M; Weatherall M; Beasley R
Respir Med; 2006 Jan; 100(1):20-5. PubMed ID: 15936933
[TBL] [Abstract][Full Text] [Related]
19. [Acute effect of inhaled beta(2)-agonists with different type of intrinsic activity on airway resistance in healthy volunteers].
Kishimoto N; Ohnishi H; Fujita J; Kamei T; Tada S; Ueda N
Arerugi; 2004 Apr; 53(4):417-22. PubMed ID: 15187486
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of procaterol and albuterol (salbutamol) aerosol in the treatment of asthma.
Mazza JA; Tashkin DP; Reed CE
Ann Allergy; 1992 Mar; 68(3):267-73. PubMed ID: 1532117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
